Detalles de la búsqueda
1.
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.
Eur Arch Psychiatry Clin Neurosci
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558147
2.
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
Eur Arch Psychiatry Clin Neurosci
; 273(1): 51-63, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262795
3.
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Eur Arch Psychiatry Clin Neurosci
; 273(7): 1615-1628, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717399
4.
Subthreshold depression - concept, operationalisation and epidemiological data. A scoping review.
Int J Psychiatry Clin Pract
; 27(1): 92-106, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736807
5.
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.
Int J Psychiatry Clin Pract
; 27(3): 285-291, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021969
6.
Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain.
Int J Psychiatry Clin Pract
; 27(1): 59-68, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35801359
7.
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature survey.
Int J Psychiatry Clin Pract
; 26(3): 277-286, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34314295
8.
Sick leave duration as a potential marker of functionality and disease severity in depression.
Int J Psychiatry Clin Pract
; 26(4): 406-416, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373692
9.
No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
Int J Neuropsychopharmacol
; 24(3): 171-180, 2021 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300578
10.
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case report.
Fortschr Neurol Psychiatr
; 89(4): 178-181, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32575133
11.
Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany.
Int J Psychiatry Clin Pract
; 25(4): 393-402, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543170
12.
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
Eur Arch Psychiatry Clin Neurosci
; 269(2): 183-193, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150713
13.
The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice.
Eur Arch Psychiatry Clin Neurosci
; 266(8): 725-736, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27002521
14.
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
Int J Neuropsychopharmacol
; 17(6): 859-69, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24456909
15.
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.
Eur Psychiatry
; 67(1): e23, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425206
16.
The best next drug in the course of generalized anxiety disorders: the "PN-GAD-algorithm".
Int J Psychiatry Clin Pract
; 17(2): 78-89, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22917251
17.
Effect of anxiolytic drug silexan on sleep - a narrative review.
World J Biol Psychiatry
; 23(7): 493-500, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259937
18.
[Positive vote for hypericum therapy is reaffirmed]. / Positives Votum für Johanniskraut-Therapie bekräftigt.
MMW Fortschr Med
; 158(7): 68-9, 2016 Apr 14.
Artículo
en Alemán
| MEDLINE | ID: mdl-27183663
19.
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers.
J Psychiatr Res
; 136: 543-551, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221027
20.
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
Wien Med Wochenschr
; 160(21-22): 547-56, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21170695